• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fortrea Holdings Inc. - Common Stock (NQ: FTRE )

    23.13 +0.50 (+2.21%)
    Streaming Delayed Price Updated: 10:35 AM EDT, Aug 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Fortrea Holdings Inc. - Common Stock

    < Previous 1 2 3 Next >
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Earnings Scheduled For March 11, 2024
    Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million. 
    Via Benzinga
    Key Takeaways From Fortrea Holdings Analyst Ratings
    Via Benzinga
    Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday
    With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024
    Biotech stocks are often at the forefront of innovation. These picks are worth considering for your portfolio for their growth potential. 
    Via InvestorPlace
    Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
    Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients 
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Expert Outlook: Fortrea Holdings Through The Eyes Of 5 Analysts
    Via Benzinga
    Where Fortrea Holdings Stands With Analysts
    Via Benzinga
    The Latest Analyst Ratings for Fortrea Holdings
    Via Benzinga
    Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
    Companies partner to provide patients and sites with easy access to study information in one integrated solution 
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Why Fortrea Holdings Shares Are Gaining Today
    Activist hedge fund Starboard Value holds a  
    Via Benzinga
    Fortrea Previews J.P. Morgan Healthcare Conference Updates
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
    The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now. 
    Via InvestorPlace
    Fortrea Convenes New Site Advisory Board
    Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships 
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?
    Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in  
    Via Benzinga
    Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
    Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies 
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
    The company's first quarter as a separate entity was better than anticipated. 
    Via The Motley Fool
    Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday
    U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For November 13, 2023
    Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
    Via Benzinga
    Fortrea Reports Third Quarter 2023 Results
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
    Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers 
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit
    From Starboard Value LP
    Via Business Wire
    Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team
    Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access 
    From Fortrea Holdings Inc
    Via GlobeNewswire
    Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call
    From Fortrea Holdings Inc
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.